Compare · AXGN vs ITOC
AXGN vs ITOC
Side-by-side comparison of Axogen Inc. (AXGN) and iTonic Holdings Ltd (ITOC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AXGN and ITOC operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- AXGN is the larger of the two at $2.66B, about 76.6x ITOC ($34.7M).
- AXGN has been more active in the news (8 items in the past 4 weeks vs 3 for ITOC).
- AXGN has more recent analyst coverage (9 ratings vs 0 for ITOC).
- Company
- Axogen Inc.
- iTonic Holdings Ltd
- Price
- $45.28-0.33%
- $0.29-6.05%
- Market cap
- $2.66B
- $34.7M
- 1M return
- -
- +1.15%
- 1Y return
- -
- -67.38%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2024
- News (4w)
- 8
- 3
- Recent ratings
- 9
- 0
Axogen Inc.
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
Latest AXGN
- SEC Form 424B5 filed by Axogen Inc.
- Amendment: Axogen Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- Axogen Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock
- Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies
- Director Tyndall Joseph A. sold $173,940 worth of shares (3,500 units at $49.70) as part of a pre-agreed trading plan, decreasing direct ownership by 25% to 10,650 units (SEC Form 4)
- Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference
- Truist initiated coverage on AxoGen with a new price target
- EVP & General Counsel Began Marc A exercised 67,500 shares at a strike of $8.16 and sold $3,195,788 worth of shares (67,500 units at $47.34) as part of a pre-agreed trading plan (SEC Form 4)
- Director Wendell Amy Mcbride exercised 13,353 shares at a strike of $14.85 and sold $646,592 worth of shares (13,353 units at $48.42) as part of a pre-agreed trading plan (SEC Form 4)
Latest ITOC
- SEC Form 6-K filed by iTonic Holdings Ltd
- SEC Form 6-K filed by iTonic Holdings Ltd
- SEC Form 6-K filed by iTonic Holdings Ltd
- iTonic Holdings Ltd Issues an Update on its Effort to Develop AI-Powered Cloud Healthcare Platform Designed to Support Nuclear Medicine Treatment Planning and with Potential Future Expansion into Digital Care Delivery
- SEC Form 6-K filed by iTonic Holdings Ltd
- SEC Form 6-K filed by iTonic Holdings Ltd
- SEC Form 6-K filed by iTonic Holdings Ltd
- iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule
- SEC Form 3 filed by new insider Zhang Jianfei
- Amendment: SEC Form 20-F/A filed by iTonic Holdings Ltd